Additionally, achieving glucose control in people with type 2 diabetes has been shown to decrease the occurrence of major microvascular and macrovascular events (113)
What to monitor Track the following metrics to assess whether the levocarnitine addition is providing value: Body composition changes (use DEXA, InBody, or similar if accessible) Energy levels and exercise performance GI symptoms (compare to baseline on tirzepatide alone if possible) Liver function markers (ALT, AST) if baseline values were elevated General well-being and recovery quality If after 8 to 12 weeks the levocarnitine addition has not produced noticeable improvements in energy, exercise performance, or body composition compared to tirzepatide alone, consider adjusting your protocol or switching to a different compound blend
HHD is a rare condition often refractory to treatment that has been successfully managed with a GLP-1 agonist in one case in the literature
The mitochondrial one-carbon metabolic pathway is associated with patient survival in pancreatic cancer
Type of Procedure: Non-surgical
We recommend asking questions to ensure you feel completely comfortable with the process
